|Common variants at five new loci associated with early-onset inflammatory bowel disease|
M Imielinski, RN Baldassano, A Griffiths, RK Russell, V Annese, ...
Nature genetics 41 (12), 1335-1340, 2009
|The diagnostic approach to monogenic very early onset inflammatory bowel disease|
HH Uhlig, T Schwerd, S Koletzko, N Shah, J Kammermeier, A Elkadri, ...
Gastroenterology 147 (5), 990-1007. e3, 2014
|Interleukin-10 receptor signaling in innate immune cells regulates mucosal immune tolerance and anti-inflammatory macrophage function|
DS Shouval, A Biswas, JA Goettel, K McCann, E Conaway, NS Redhu, ...
Immunity 40 (5), 706-719, 2014
|IL-10R polymorphisms are associated with very-early-onset ulcerative colitis|
CJ Moran, TD Walters, CH Guo, S Kugathasan, C Klein, D Turner, ...
Inflammatory bowel diseases 19 (1), 115-123, 2013
|Eating disorders in adolescent boys: a review of the adolescent and young adult literature|
AM Muise, DG Stein, G Arbess
Journal of Adolescent Health 33 (6), 427-435, 2003
|Clinical outcome in IL-10–and IL-10 receptor–deficient patients with or without hematopoietic stem cell transplantation|
KR Engelhardt, N Shah, I Faizura-Yeop, DFK Uygun, N Frede, AM Muise, ...
Journal of Allergy and Clinical Immunology 131 (3), 825-830. e9, 2013
|Interleukin 10 receptor signaling: master regulator of intestinal mucosal homeostasis in mice and humans|
DS Shouval, J Ouahed, A Biswas, JA Goettel, BH Horwitz, C Klein, ...
Advances in immunology 122, 177-210, 2014
|Incidence, outcomes, and health services burden of very early onset inflammatory bowel disease|
EI Benchimol, DR Mack, GC Nguyen, SB Snapper, W Li, N Mojaverian, ...
Gastroenterology 147 (4), 803-813. e7, 2014
|A eukaryotic transcriptional represser with carboxypeptidase activity|
GP He, A Muise, AW Li, HS Ro
Nature 378 (6552), 92-96, 1995
|Mutations in tetratricopeptide repeat domain 7A result in a severe form of very early onset inflammatory bowel disease|
Y Avitzur, C Guo, LA Mastropaolo, E Bahrami, H Chen, Z Zhao, A Elkadri, ...
Gastroenterology 146 (4), 1028-1039, 2014
|NADPH oxidase complex and IBD candidate gene studies: identification of a rare variant in NCF2 that results in reduced binding to RAC2|
AM Muise, W Xu, CH Guo, TD Walters, VM Wolters, R Fattouh, GY Lam, ...
Gut 61 (7), 1028-1035, 2012
|Polymorphisms in E-cadherin (CDH1) result in a mis-localised cytoplasmic protein that is associated with Crohn’s disease|
AM Muise, TD Walters, WK Glowacka, AM Griffiths, BY Ngan, H Lan, W Xu, ...
Gut 58 (8), 1121-1127, 2009
|Regulation of adipogenesis by a transcriptional repressor that modulates MAPK activation|
SW Kim, AM Muise, PJ Lyons, HS Ro
Journal of Biological Chemistry 276 (13), 10199-10206, 2001
|Loss of the Arp2/3 complex component ARPC1B causes platelet abnormalities and predisposes to inflammatory disease|
WHA Kahr, FG Pluthero, A Elkadri, N Warner, M Drobac, CH Chen, RW Lo, ...
Nature communications 8 (1), 1-14, 2017
|Listeria monocytogenes exploits efferocytosis to promote cell-to-cell spread|
MA Czuczman, R Fattouh, JM van Rijn, S Osborne, AM Muise, ...
Nature 509 (7499), 230-234, 2014
|Host and bacterial factors that regulate LC3 recruitment to Listeria monocytogenes during the early stages of macrophage infection|
GY Lam, M Cemma, AM Muise, DE Higgins, JH Brumell
Autophagy 9 (7), 985-995, 2013
|Interleukin 1β mediates intestinal inflammation in mice and patients with interleukin 10 receptor deficiency|
DS Shouval, A Biswas, YH Kang, AE Griffith, L Konnikova, ID Mascanfroni, ...
Gastroenterology 151 (6), 1100-1104, 2016
|Variants in nicotinamide adenine dinucleotide phosphate oxidase complex components determine susceptibility to very early onset inflammatory bowel disease|
SS Dhillon, R Fattouh, A Elkadri, W Xu, R Murchie, T Walters, C Guo, ...
Gastroenterology 147 (3), 680-689. e2, 2014
|Defects in nicotinamide-adenine dinucleotide phosphate oxidase genes NOX1 and DUOX2 in very early onset inflammatory bowel disease|
P Hayes, S Dhillon, K O’Neill, C Thoeni, KY Hui, A Elkadri, CH Guo, ...
Cellular and molecular gastroenterology and hepatology 1 (5), 489-502, 2015
|Infliximab maintains durable response and facilitates catch-up growth in luminal pediatric Crohn's disease|
PC Church, J Guan, TD Walters, K Frost, A Assa, AM Muise, AM Griffiths
Inflammatory bowel diseases 20 (7), 1177-1186, 2014